NHS trials AI phone assistant for long-term conditions; Barts adds AI to breast cancer MDTs; Palantir tools underused
The NHS is trialling an AI phone assistant to monitor patients with long-term conditions, and Barts Health is introducing AI decision support in breast cancer multidisciplinary team meetings. A report says many of the 29 NHS trusts said to benefit from Palantir's AI technology use it little or not at all.
Who is affected and how
- doctor
- Multidisciplinary team decision support and remote monitoring are being built into everyday care pathways.
- hospital manager
- Unused tools show that procurement alone is not enough; the rollout plan and actual use must be measured too.
- health IT
- Actual use and value delivered by vendor platforms must be demonstrated.
Sources
- NHS trials AI phone assistant to monitor patients with long-term illnessuniversity of york · Nov 5, 2026
- AI glucose monitor now available on the NHS for patients in Devonmidweek herald · Nov 5, 2026
- NHS trials AI phone assistant to monitor patients with long-term illness - News and events, University of Yorkyork.ac.uk · Nov 6, 2026
- Barts Health to deploy AI decision support in breast cancer MDTshome | digital health · Nov 4, 2026
- Barts decide on AI for breast cancer treatmentukauthority.com · Nov 5, 2026
- Palantir AI tech unused or little used by 29 NHS trusts said to be benefiting from itthe guardian · Nov 2, 2026
- Palantir AI tech unused or little used by 29 NHS trusts said to be benefiting from it | Palantir | The Guardiantheguardian.com · Nov 2, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.